InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $71.81 million as of December 5, 2025. Its market cap has decreased by -29.94% in one year.
Market Cap
71.81M
Enterprise Value
20.89M
1-Year Change
-29.94%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $71.81M, a decrease of -79.53%. That is a compound annual growth rate of -17.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 74.50M | -48.76% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |